CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
50.91
-1.07 (-2.07%)
Feb 5, 2026, 12:53 PM EST - Market open
CG Oncology Employees
CG Oncology had 113 employees as of December 31, 2024. The number of employees increased by 52 or 85.25% compared to the previous year.
Employees
113
Change (1Y)
52
Growth (1Y)
85.25%
Revenue / Employee
$19,239
Profits / Employee
-$1,340,566
Market Cap
4.11B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 113 | 52 | 85.25% |
| Dec 31, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 685 |
| ACADIA Pharmaceuticals | 654 |
| Corcept Therapeutics | 500 |
| Amicus Therapeutics | 499 |
| TG Therapeutics | 374 |
| Apogee Therapeutics | 196 |
| Liquidia | 170 |
| Arcellx | 163 |
CGON News
- 20 days ago - CG Oncology, Inc. (CGON) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 25 days ago - CG Oncology: 'Strong Buy' On Earlier Than Expected Completed Recruitment Cretostimogene - Seeking Alpha
- 27 days ago - CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC - GlobeNewsWire
- 4 weeks ago - CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - CG Oncology Undervalued Going Into A Busy 2026 - Seeking Alpha
- 2 months ago - New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer - GlobeNewsWire
- 2 months ago - CG Oncology Announces New Board Member and Board Transition - GlobeNewsWire
- 2 months ago - CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire